FGG

Chr 4

fibrinogen gamma chain

The protein encoded by this gene is the gamma component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia and thrombophilia. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.54
Clinical SummaryFGG
🧬
Gene-Disease Validity (ClinGen)
congenital fibrinogen deficiency · SDDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.29) despite low pLI — interpret in context.
📋
ClinVar Variants
34 unique Pathogenic / Likely Pathogenic· 110 VUS of 210 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.54LOEUF
pLI 0.050
Z-score 3.28
OE 0.29 (0.160.54)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.20Z-score
OE missense 0.78 (0.690.88)
184 obs / 235.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.29 (0.160.54)
00.351.4
Missense OE?0.78 (0.690.88)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 7 / 24.5Missense obs/exp: 184 / 235.8Syn Z: -0.14

This gene — mechanism propensity

DN
0.6550th %ile
GOF
0.6639th %ile
LOF
0.2386th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

210 submitted variants in ClinVar

Classification Summary

Pathogenic15
Likely Pathogenic19
VUS110
Likely Benign37
Benign12
Conflicting15
15
Pathogenic
19
Likely Pathogenic
110
VUS
37
Likely Benign
12
Benign
15
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
6
5
4
0
15
Likely Pathogenic
6
12
1
0
19
VUS
2
97
8
3
110
Likely Benign
1
4
13
19
37
Benign
0
0
9
3
12
Conflicting
15
Total151183525208

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

30 pathogenic / likely-pathogenic (of 34) ClinVar copy-number / structural variants overlap FGG — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

FGG · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →